Belmac Corp. of Tampa, Fla., said that Donald Boultbee has beennamed president and chief executive officer. Boultbee was areavice president of Latin American and certain Middle East andFar East markets for SmithKline Beecham. He has also served asa strategic planning consultant with major pharmaceutical andbiotechnology companies, and as a director of Euromedia.

Michael Dougherty was named senior vice president and chieffinancial officer of Magainin Pharmaceuticals Inc. of PlymouthMeeting, Pa. Dougherty was senior vice president and chieffinancial officer of Centocor Inc.

Biosys promoted Edwin Quattlebaum to president and chiefoperating officer. Quattlebaum joined Biosys of Palo Alto, Calif.,last year from Rhone-Poulenc Rohrer. Venkat Sohoni willremain chief executive officer, with the added title of vicechairman of the board. In addition, the company said MiltonFriedman will resign as vice president of research.

Seragen Inc. of Hopkinton, Mass., named Thomas Konatich vicepresident for finance and chief financial officer. Konatich wasCFO, treasurer and director for Ohmicron Corp.

Daniel Petree was named vice president of corporatedevelopment and chief financial officer of Arris PharmaceuticalCorp. of South San Francisco, Calif. Petree was vice president ofbusiness development at TSI Corp.

(c) 1997 American Health Consultants. All rights reserved.